Skip to main content
. 2016 Apr 29;8(2):95–103. doi: 10.5114/jcb.2016.59686

Fig. 2.

Fig. 2

Receiver operating characteristic (ROC) curve analysis to evaluate an optimal cut-point of prostate specific antigen nadir after the radiotherapy as a predictive value for biochemical failure (AUC-ROC = 0.815, 95% CI: 0.697- 0.933, p < 0.001)